Key result
Transcatheter aortic valve replacement for a degenerated bioprosthetic valve resulted in a rare case of valve embolization due to device malpositioning, which required subsequent management.
Why the study?
Transcatheter aortic valve-in-valve is an alternative for failed surgical bioprostheses, but concerns include safety risks such as device malposition.
Case Report (n=1)
Highlights a rare complication of TAVR valve embolization due to device malpositioning during a valve-in-valve procedure and its management.
Transcatheter aortic valve in valve is an emerging alternative therapeutic intervention for patients with a failed surgical bioprosthesis in view of significant reoperative morbidity and mortality associated with redo surgery. The valve-in-valve procedure is clinically effective in vast majority of patients with degenerated bioprosthetic valves. Safety and efficacy concerns include device malposition, ostial coronary obstruction, and high gradients after the procedure. We hereby present a rare case of transcatheter aortic valve replacement valve embolization due to device malpositioning and its subsequent management.
No takes yet. Share an insight, caveat, or question.
Bhastana et al. (2025) conducted a case report in Degenerative Bioprosthetic Mosaic Valve (n=1). Transcatheter aortic valve replacement (valve-in-valve) was evaluated on Valve embolization and subsequent management. Transcatheter aortic valve replacement for a degenerated bioprosthetic valve resulted in a rare case of valve embolization due to device malpositioning, which required subsequent management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: